Overview

Ramelteon 8 mg Tablets Specified Drug-use Survey: - Transitional Survey From the Preceding Drug-use Survey -

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this survey is to examine the safety and efficacy of long-term use of ramelteon tablets (Rozerem 8 mg Tablets) in participants with difficulty falling asleep associated with insomnia in daily medical practice.

Details

Lead Sponsor:

Takeda